Log In
Print
BCIQ
Print
Print this Print this
 

Engauge-cancer-DLBCL

  Manage Alerts
Collapse Summary General Information
Company Diagnovus LLC
DescriptionGene expression assay that combines LMO2 and CD137 (TNFRSF9) gene expression levels with the International Prognostic Index (IPI)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose and stratify patients with diffuse large B cell lymphoma (DLBCL)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today